Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2024 - 2030

Table of content

Chapter 1 Biopharmaceutical CMO And CRO Market: Research Methodology
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing
Chapter 2 Biopharmaceutical CMO And CRO Market: Executive Summary
                   2.1 Biopharmaceutical CMO & CRO Market Outlook, 2018 - 2030
Chapter 3 Biopharmaceutical CMO And CRO Market: Variables, Trends, & Scope
                   3.1 Market Liniage
                       3.1.1 Parent Market
                       3.1.2 Ancialiary Market
                   3.2 Biopharmaceutical CMO & CRO Market: Market Dynamics
                       3.2.1 Market driver analysis
                           3.2.1.1 Rising investment by CMOs for capacity expansion
                           3.2.1.2 Commercial success of biopharmaceuticals and consequent increased demand for the biopharmaceuticals
                           3.2.1.3 Robust biopharmaceuticals pipeline
                           3.2.1.4 Cost and time saving benefits offered by contract services
                       3.2.2 Market restraint analysis
                           3.2.2.1 Limited outsourcing amongst well-stablished biopharmaceutical manufacturer
                   3.4 Key Opportunity Analysis
                       3.4.1 Rising funds in biopharmaceutical indutry
                       3.4.2 Mergers & acquistion for facility expansion
                       3.4.3 Growing demand for protein therapeutics
                   3.5 Industry Analysis - Porter’s
                       3.5.1 Supplier Power: Substantial number of suppliers for bioprocessing equipment contributes to the low supplier power
                       3.5.2 Buyer Power: Fragmented nature of biopharmaceutical industry has led to moderate bargaining power of buyers
                       3.5.3 Substitution Threat: High due to presence of several big pharma companies
                       3.5.4 New Entrants Threat: Presence of established players coupled with need of adequate capacity results in moderate threat of new entrants
                       3.5.5 Competitive Rivalry: High due to fragmented nature of market
                   3.6 Biopharmaceuticals CMO & CRO PEST Analysis
                       3.6.1 Political landscape
                       3.6.2 Economic landscape
                       3.6.3 Social landscape
                       3.6.4 Technology landscape
                   3.7 COVID-19 Impact and Reformation Analysis
Chapter 4. Biopharmaceuticals CMO & CRO Market: Source Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. Biopharmaceuticals CMO & CRO : Source Movement Analysis, 2023 & 2030 (USD Billion)
                   4.3. Mammalian Source
                       4.3.1. Mammalian Source Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   4.4. Non-Mammalian Source
                       4.4.1. Non-Mammalian Source Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Biopharmaceuticals CMO & CRO Market: Service Type Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. Biopharmaceuticals CMO & CRO Market: Service Type Movement Analysis, 2023 & 2030 (USD Billion)
                   5.3. Contract Manufacturing
                       5.3.1. Contract Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       5.3.2. Process Development
                           5.3.2.1. Process Development Market, 2018 - 2030 (USD Billion)
                           5.3.2.2. Downstream Processing
                               5.3.2.2.1. Downstream Processing Market, 2018 - 2030 (USD Billion)
                           5.3.2.3. Upstream Processing
                               5.3.2.3.1. Upstream Processing Market, 2018 - 2030 (USD Billion)
                       5.3.3. Fill & Finish Operations
                           5.3.3.1. Fill & Finish Operations Market, 2018 - 2030 (USD Billion)
                       5.3.4. Analytical & Qc Testing
                           5.3.4.1. Analytical & Qc Testing Market, 2018 - 2030 (USD Billion)
                       5.3.5. Packaging
                           5.3.5.1. Packaging Market, 2018 - 2030 (USD Billion)
                   5.4. Contract Research
                       5.4.1. Contract Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       5.4.2. Oncology
                           5.4.2.1. Oncology Market, 2018 - 2030 (USD Billion)
                       5.4.3. Cardiology
                           5.4.3.1. Cardiology Market, 2018 - 2030 (USD Billion)
                       5.4.4. Neuroscience
                           5.4.4.1. Neuroscience Market, 2018 - 2030 (USD Billion)
                       5.4.5. Others
                               5.4.5.1.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 6. Biopharmaceuticals CMO & CRO Market: Product Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. Biopharmaceuticals CMO & CRO Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
                   6.3. Biologics
                       6.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       6.3.2. Monoclonal Antibodies
                           6.3.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
                       6.3.3. Recombinant Proteins
                           6.3.3.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
                       6.3.4. Vaccines
                           6.3.4.1. Vaccines Market, 2018 - 2030 (USD Billion)
                       6.3.5. Antisense, RNAi, & Molecular Therapy
                           6.3.5.1. Antisense, Rnai, & Molecular Therapy Market, 2018 - 2030 (USD Billion)
                           6.3.5.2. Others
                       6.3.6. Others Market, 2018 - 2030 (USD Billion)
                   6.4. Biosimilars
                       6.4.1. Biosimilars Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Biopharmaceuticals CMO & CRO Market: Regional Estimates & Trend Analysis
                   7.1. Biopharmaceuticals CMO & CRO Market Share, By Region, 2023 & 2030, USD Billion
                   7.2. North America
                       7.2.1. North America Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.2.2. U.S.
                           7.2.2.1. Key Country Dynamics
                           7.2.2.2. Regulatory Landscape/Reimbursement Scenario
                           7.2.2.3. Competitive Insights
                           7.2.2.4. U.S. Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.2.3. Canada
                           7.2.3.1. Key Country Dynamics
                           7.2.3.2. Regulatory Landscape/Reimbursement Scenario
                           7.2.3.3. Competitive Insights
                           7.2.3.4. Canada Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.3. Europe
                       7.3.1. Europe Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.2. U.K.
                           7.3.2.1. Key Country Dynamics
                           7.3.2.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.2.3. Competitive Insights
                           7.3.2.4. U.K. Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.3. Germany
                           7.3.3.1. Key Country Dynamics
                           7.3.3.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.3.3. Competitive Insights
                           7.3.3.4. Germany Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.4. France
                           7.3.4.1. Key Country Dynamics
                           7.3.4.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.4.3. Competitive Insights
                           7.3.4.4. France Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.5. Italy
                           7.3.5.1. Key Country Dynamics
                           7.3.5.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.5.3. Competitive Insights
                           7.3.5.4. Italy Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.6. Spain
                           7.3.6.1. Key Country Dynamics
                           7.3.6.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.6.3. Competitive Insights
                           7.3.6.4. Spain Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.7. Sweden
                           7.3.7.1. Key Country Dynamics
                           7.3.7.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.7.3. Competitive Insights
                           7.3.7.4. Sweden Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.8. Denmark
                           7.3.8.1. Key Country Dynamics
                           7.3.8.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.8.3. Competitive Insights
                           7.3.8.4. Denmark Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.9. Norway
                           7.3.9.1. Key Country Dynamics
                           7.3.9.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.9.3. Competitive Insights
                           7.3.9.4. Norway Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.3.10. Netherland
                           7.3.10.1. Key Country Dynamics
                           7.3.10.2. Regulatory Landscape/Reimbursement Scenario
                           7.3.10.3. Competitive Insights
                           7.3.10.4. Netherland Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.4. Asia Pacific
                       7.4.1. Asia Pacific Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.2. China
                           7.4.2.1. Key Country Dynamics
                           7.4.2.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.2.3. Competitive Insights
                           7.4.2.4. China Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.3. Japan
                           7.4.3.1. Key Country Dynamics
                           7.4.3.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.3.3. Competitive Insights
                           7.4.3.4. Japan Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.4. India
                           7.4.4.1. Key Country Dynamics
                           7.4.4.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.4.3. Competitive Insights
                           7.4.4.4. India Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.5. South Korea
                           7.4.5.1. Key Country Dynamics
                           7.4.5.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.5.3. Competitive Insights
                           7.4.5.4. South Korea Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.6. Australia
                           7.4.6.1. Key Country Dynamics
                           7.4.6.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.6.3. Competitive Insights
                           7.4.6.4. Australia Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.4.7. Thailand
                           7.4.7.1. Key Country Dynamics
                           7.4.7.2. Regulatory Landscape/Reimbursement Scenario
                           7.4.7.3. Competitive Insights
                           7.4.7.4. Thailand Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.5. Latin America
                       7.5.1. Latin America Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.5.2. Brazil
                           7.5.2.1. Key Country Dynamics
                           7.5.2.2. Regulatory Landscape/Reimbursement Scenario
                           7.5.2.3. Competitive Insights
                           7.5.2.4. Brazil Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.5.3. Mexico
                           7.5.3.1. Key Country Dynamics
                           7.5.3.2. Regulatory Landscape/Reimbursement Scenario
                           7.5.3.3. Competitive Insights
                           7.5.3.4. Mexico Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.5.4. Argentina
                           7.5.4.1. Key Country Dynamics
                           7.5.4.2. Regulatory Landscape/Reimbursement Scenario
                           7.5.4.3. Competitive Insights
                           7.5.4.4. Argentina Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.6. Middle East and Africa
                       7.6.1. Middle East and Africa Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.6.2. Saudi Arabia
                           7.6.2.1. Key Country Dynamics
                           7.6.2.2. Regulatory Landscape/Reimbursement Scenario
                           7.6.2.3. Competitive Insights
                           7.6.2.4. Saudi Arabia Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.6.3. UAE
                           7.6.3.1. Key Country Dynamics
                           7.6.3.2. Regulatory Landscape/Reimbursement Scenario
                           7.6.3.3. Competitive Insights
                           7.6.3.4. UAE Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.6.4. South Africa
                           7.6.4.1. Key Country Dynamics
                           7.6.4.2. Regulatory Landscape/Reimbursement Scenario
                           7.6.4.3. Competitive Insights
                           7.6.4.4. South Africa Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       7.6.5. Kuwait
                           7.6.5.1. Key Country Dynamics
                           7.6.5.2. Regulatory Landscape/Reimbursement Scenario
                           7.6.5.3. Competitive Insights
                           7.6.5.4. Kuwait Biopharmaceuticals CMO & CRO Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis by Key Market Participants
                   8.2. Company Categorization
                   8.3. Company Market Share Analysis
                   8.4. Company Heat Map Analysis
                   8.5. Strategy Mapping
                       8.5.1. Expansion
                       8.5.2. Mergers & Acquisition
                       8.5.3. Partnerships & Collaborations
                       8.5.4. New Product Launches
                       8.5.5. Research And Development
                   8.6. Company Profiles
                       8.6.1. Boehringer Ingelheim GmbH
                           8.6.1.1. Participant’s Overview
                           8.6.1.2. Financial Performance
                           8.6.1.3. Product Benchmarking
                           8.6.1.4. Recent Developments
                       8.6.2. LONZA
                           8.6.2.1. Participant’s Overview
                           8.6.2.2. Financial Performance
                           8.6.2.3. Product Benchmarking
                           8.6.2.4. Recent Developments
                       8.6.3. Inno Biologics Sdn Bhd
                           8.6.3.1. Participant’s Overview
                           8.6.3.2. Financial Performance
                           8.6.3.3. Product Benchmarking
                           8.6.3.4. Recent Developments
                       8.6.4. Rentschler Biotechnologie GmbH
                           8.6.4.1. Participant’s Overview
                           8.6.4.2. Financial Performance
                           8.6.4.3. Product Benchmarking
                           8.6.4.4. Recent Developments
                       8.6.5. JRS PHARMA
                           8.6.5.1. Participant’s Overview
                           8.6.5.2. Financial Performance
                           8.6.5.3. Product Benchmarking
                           8.6.5.4. Recent Developments
                       8.6.6. BIOMEVA GmbH
                           8.6.6.1. Participant’s Overview
                           8.6.6.2. Financial Performance
                           8.6.6.3. Product Benchmarking
                           8.6.6.4. Recent Developments
                       8.6.7. ProBioGen
                           8.6.7.1. Participant’s Overview
                           8.6.7.2. Financial Performance
                           8.6.7.3. Product Benchmarking
                           8.6.7.4. Recent Developments
                       8.6.8. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
                           8.6.8.1. Participant’s Overview
                           8.6.8.2. Financial Performance
                           8.6.8.3. Product Benchmarking
                           8.6.8.4. Recent Developments
                       8.6.9. TOYOBO CO., LTD.
                           8.6.9.1. Participant’s Overview
                           8.6.9.2. Financial Performance
                           8.6.9.3. Product Benchmarking
                           8.6.9.4. Recent Developments
                       8.6.10. Thermo Fisher Scientific Inc
                           8.6.10.1. Participant’s Overview
                           8.6.10.2. Financial Performance
                           8.6.10.3. Product Benchmarking
                           8.6.10.4. Recent Developments
                       8.6.11. CMC Biologics
                           8.6.11.1. Participant’s Overview
                           8.6.11.2. Financial Performance
                           8.6.11.3. Product Benchmarking
                           8.6.11.4. Recent Developments
                       8.6.12. Binex Co., Ltd.
                           8.6.12.1. Participant’s Overview
                           8.6.12.2. Financial Performance
                           8.6.12.3. Product Benchmarking
                           8.6.12.4. Recent Developments
                       8.6.13. WuXi Biologics
                           8.6.13.1. Participant’s Overview
                           8.6.13.2. Financial Performance
                           8.6.13.3. Product Benchmarking
                           8.6.13.4. Recent Developments
                       8.6.14. AbbVie, Inc.
                           8.6.14.1. Participant’s Overview
                           8.6.14.2. Financial Performance
                           8.6.14.3. Product Benchmarking
                           8.6.14.4. Recent Developments
                       8.6.15. Charles River Laboratories International, Inc
                           8.6.15.1. Participant’s Overview
                           8.6.15.2. Financial Performance
                           8.6.15.3. Product Benchmarking
                           8.6.15.4. Recent Developments
                       8.6.16. ICON plc.
                           8.6.16.1. Participant’s Overview
                           8.6.16.2. Financial Performance
                           8.6.16.3. Product Benchmarking
                           8.6.16.4. Recent Developments
                       8.6.17. Laboratory Corporation of America Holdings
                           8.6.17.1. Participant’s Overview
                           8.6.17.2. Financial Performance
                           8.6.17.3. Product Benchmarking
                           8.6.17.4. Recent Developments
                       8.6.18. Parexel International Corporation
                           8.6.18.1. Participant’s Overview
                           8.6.18.2. Financial Performance
                           8.6.18.3. Product Benchmarking
                           8.6.18.4. Recent Developments

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 4 Global biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 5 Global biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 6 Global biopharmaceutical CMO & CRO market, by region, 2018 - 2030 (USD Billion)
Table 7 North America biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Billion)
Table 8 North America biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 9 North America biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 10 North America biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 11 U.S. biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 12 U.S. biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 13 U.S. biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 14 Canada biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 15 Canada biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 16 Canada biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 17 Europe biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Billion)
Table 18 Europe biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 19 Europe biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 20 Europe biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 21 Germany biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 22 Germany biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 23 Germany biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 24 UK biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 25 UK biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 26 UK biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 27 France biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 28 France biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 29 France biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 30 Italy biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 31 Italy biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 32 Italy biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 33 Spain biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 34 Spain biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 35 Spain biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 36 Denmark biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 37 Denmark biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 38 Denmark biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 39 Sweden biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 40 Sweden biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 41 Sweden biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 42 Norway biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 43 Norway biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 44 Norway biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 45 Asia Pacific biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Billion)
Table 46 Asia Pacific biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 47 Asia Pacific biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 48 Asia Pacific biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 49 Japan biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 50 Japan biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 51 Japan biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 52 China biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 53 China biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 54 China biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 55 India biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 56 India biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 57 India biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 58 Australia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 59 Australia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 60 Australia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 61 South Korea biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 62 South Korea biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 63 South Korea biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 64 Thailand biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 65 Thailand biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 66 Thailand biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 67 Latin America biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Billion)
Table 68 Latin America biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 69 Latin America biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 70 Latin America biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 71 Brazil biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 72 Brazil biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 73 Brazil biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 74 Mexico biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 75 Mexico biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 76 Mexico biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 77 Argentina biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 78 Argentina biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 79 Argentina biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 80 Colombia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 81 Colombia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 82 Colombia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 83 Middle East & Africa biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Billion)
Table 84 Middle East & Africa biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 85 Middle East & Africa biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 86 Middle East & Africa biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 87 South Africa biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 88 South Africa biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 89 South Africa biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 90 Saudi Arabia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 91 Saudi Arabia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 92 Saudi Arabia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 93 UAE biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 94 UAE biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 95 UAE biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)
Table 96 Kuwait biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Billion)
Table 97 Kuwait biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Billion)
Table 98 Kuwait biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 Biopharmaceutical CMO & CRO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Cumulative success rate comparison of biologics with small molecules over time
Fig. 12 Number of biologics investigational new drugs, 2005-2021
Fig. 13 Number of Reference Products by U.S. Biosimilars Launchable Dates
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Risk associated with outsourcing services
Fig. 16 PEST Analysis (political & legal, economic and technological)
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Company market share analysis
Fig. 19 Strategy framework
Fig. 20 Participant categorization
Fig. 21 CMO selection process
Fig. 22 Trends in the biopharmaceutical industry
Fig. 23 R&D process of biopharmaceutical development
Fig. 24 Development phases where outsourcing partners are engaged
Fig. 25 Global biopharmaceuticals CMO & CRO market: Source outlook key takeaways
Fig. 26 Global Biopharmaceuticals CMO & CRO market: Source movement analysis
Fig. 27 Global mammalian source market, 2018 - 2030 (USD Billion)
Fig. 28 Global mammalian source market, 2018 - 2030 (USD Billion)
Fig. 29 Global biopharmaceuticals CMO & CRO market: Service type outlook key takeaways
Fig. 30 Global biopharmaceuticals CMO & CRO market: Service movement analysis
Fig. 31 Global contract manufacturing market, 2018 - 2030 (USD Billion)
Fig. 32 Percentage of biomanufacturers outsourcing some activity of upstream and downstream processing, 2011-2016
Fig. 33 Global process development market, 2018 - 2030 (USD Billion)
Fig. 34 Global downstream processing market, 2018 - 2030 (USD Billion)
Fig. 35 Global upstream processing market, 2018 - 2030 (USD Billion)
Fig. 36 Global fill & finish operations market, 2018 - 2030 (USD Billion)
Fig. 37 Global analytical & QC testing market, 2018 - 2030 (USD Billion)
Fig. 38 Global contract packaging market, 2018 - 2030 (USD Billion)
Fig. 39 Breakdown of the general CRO industry by type of service
Fig. 40 Initial attributes that play key role into CRO engagement
Fig. 41 Post-engagement attributes that play key role into CRO engagement
Fig. 42 Global contract research market, 2018 - 2030 (USD Billion)
Fig. 43 Global oncology market, 2018 - 2030 (USD Billion)
Fig. 44 Global inflammation & immunology market, 2018 - 2030 (USD Billion)
Fig. 45 Global cardiology market, 2018 - 2030 (USD Billion)
Fig. 46 Global neuroscience market, 2018 - 2030 (USD Billion)
Fig. 47 Global other CRO services market, 2018 - 2030 (USD Billion)
Fig. 48 Global biopharmaceuticals CMO & CRO market: Product outlook key takeaways
Fig. 49 Global biopharmaceuticals CMO & CRO market: Product movement analysis
Fig. 50 Global biologics market, 2018 - 2030 (USD Billion)
Fig. 51 Year wise annual approvals for MAbs products which are currently marketed in U.S./EU
Fig. 52 Share of MAbs-related R&D programs at different pipeline phases, 2015
Fig. 53 Global monoclonal antibodies market, 2018 - 2030 (USD Billion)
Fig. 54 Comparison of R&D biotech pipeline expansion for recombinant products
Fig. 55 Global recombinant proteins market, 2018 - 2030 (USD Billion)
Fig. 56 Global vaccines market, 2018 - 2030 (USD Billion)
Fig. 57 Global antisense, RNAi, &molecular therapy market, 2018 - 2030 (USD Billion)
Fig. 58 Global other product market, 2018 - 2030 (USD Billion)
Fig. 59 Global biosimilars market, 2018 - 2030 (USD Billion)
Fig. 60 Regional market place: Key takeaway
Fig. 61 Comparison of biopharmaceutical manufacturing facilities region and country wise
Fig. 62 Biopharmaceuticals CMO & CRO regional outlook, 2020 & 2028
Fig. 63 North America biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 64 Number of U.S. pharmaceutical outsourcing M&A transactions
Fig. 65 Biopharmaceuticals goods export growth comparison between 2011 and 2014
Fig. 66 U.S. biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 67 Pros and cons of Canadian pharmaceutical & biopharmaceutical industry
Fig. 68 Canada biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 69 Europe biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 70 Revenue growth of Germany pharmaceutical industry
Fig. 71 UK biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 72 Germany biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 73 France biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 74 Italy biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 75 Spain biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 76 Norway biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 77 Denmark biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 78 Sweden biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 77 Factors supporting contract manufacturing/research in Asian countries
Fig. 78 Asia Pacific biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 79 China biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 80 India biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 81 Japan biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 82 South Korea biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 83 Thailand biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 84 Australia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 85 Latin America biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 86 Brazil biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 87 Mexico biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 88 Colombia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 89 Argentina biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 90 Middle East & Africa biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 91 South Africa biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 92 Saudi Arabia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 93 UAE biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)
Fig. 94 Kuwait biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Billion)